Young blood cocktail stops Alzheimer's decline, early clinical trial reports

Alkahest, a California-based start-up, has just revealed some compelling early results from an ongoing Phase 2 trial into the efficacy of its novel formulation of plasma proteins derived from young blood, developed to slow, or even stop, the cognitive decline associated with Alzheimer’s disease.
Read more: https://newatlas.com/alkahest-young-blood-plasma-alzheimers-cognitive-decline/60927/?source=Snapzu